Sign InBreakout Stocks of Week 12 @ OMXH
NASDAQ was down last week (week 11) by -2.04% ending at 21,653.71 points after falling -451.65 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Outokumpu Oyj OMXH:OUT1V. This stock has had a buy signal since Mar 20, 2026 when the price was 4.58€ , but have so far fallen 0% to 4.58€. Some other companies are on our watchlist to, among these are which all got a breakout pattern emerging.
| Date | Company | Price | Week 12 |
|---|---|---|---|
| Outokumpu Oyj | 4.58€ | 4.62€ | 0.92% |
| Orion Oyj | 68.90€ | 67.30€ | -2.32% |
The Outokumpu Oyj stock price gained 1.10% on the last trading day (Friday, 20th Mar 2026), rising from 4.53€ to 4.58€. During the last trading day the stock fluctuated 3.51% from a day low at 4.55€ to a day high of 4.71€. The price has fallen in 6 of the last 10 days and is down by -11.24% for this period. Volume fell on the last day by -2 million shares and in total, 2 million shares were bought and sold for approximately 7.46€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Outokumpu Oyj holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Outokumpu Oyj:
Outokumpu Oyj produces and sells various stainless steel products in Finland, other European countries, North America, the Asia-Pacific, and internationally. It offers cold rolled coils, strips, and sheets; precision strips; hot rolled coils, strips, and plates; quarto plates; precise components, including welded stainless-steel I-beams, H-beams, hollow-section tubes, bent profiles, structural sections, press plates, roll shells, and blancs and disks; semi-finished stainless steel long products comprising billets and blooms, forged and rolled billets, cast slabs, ingots, and rebar; and stainless steel wire rods, wires, and bars. Its products are used in various applications, including commercial kitchen, cooking, food industry, and home appliances; automotive and transportation; building and infrastructure; energy and marine; and heavy industries. Outokumpu Oyj was founded in 1910 and is headquartered in Helsinki, Finland.
The Orion Oyj stock price fell by -1.29% on the last day (Friday, 20th Mar 2026) from 69.80€ to 68.90€. During the last trading day the stock fluctuated 2.32% from a day low at 68.90€ to a day high of 70.50€. The price has risen in 5 of the last 10 days and is up by 2.15% over the past 2 weeks. Volume has increased on the last day by 118 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 352 thousand shares were bought and sold for approximately 24.25€ million.
The Orion Oyj stock holds several negative signals and despite the positive trend, we believe Orion Oyj will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Orion Oyj:
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
IDYA
$28.98
|
7.76% | Jun 12 |
DHI
$146.71
|
7.57% | Jun 10 |
PHM
$118.49
|
7.15% | Jun 10 |
EAT
$140.46
|
17.39% | Jun 05 |
TPR
$140.47
|
2.16% | Jun 04 |
